Monocytes were obtained by gradient centrifugation of peripheral blood mononuclear cells (PBMCs) and cultured as described.
33 At day 3, 25 ng/mL of granulocyte colony‐stimulating factor (Invitrogen Corporation, Carlsbad, CA, USA) were added, and macrophages were selected by adhesion. Medium and all reagents were endotoxin free.
Macrophage lineage characterization was based on morphological study and expression of the monocytes‐macrophages lineage marker, CD14 (see below).
To block dynamin‐dependent endocytosis,
34in vitro differentiated macrophages were treated with 40 and 400 μM of
dynasore (Enzo Life Sciences, Lausen, Switzerland) for 30 minutes and processed for immunoflurescence.
Cells were also treated for 1‐24 hours with 700 nM of Hepc (Peptide Institute, Minoh‐shi Osaka, Japan) and subjected to immunofluorescence.
In specific experiments, cells were preincubated for 18 hours with 0.25 µM of dexamethasone phosphate (Dx; Sigma‐Aldrich, St. Louis, MO, USA), a known stimulator of CD163 expression and hemoglobin (Hb) uptake by macrophages,
35 and then incubated for 6 hours with 20 μg/mL of
bovine Hb (Sigma‐Aldrich). Donor macrophages were also treated with aged red blood cells as reported.
36 Cells were harvested and processed for immunofluorescence.
Cellular ferritin content and iron in the medium were assayed after overnight incubation as specified below.
Sabelli M., Montosi G., Garuti C., Caleffi A., Oliveto S., Biffo S, & Pietrangelo A. (2017). Human macrophage ferroportin biology and the basis for the ferroportin disease. Hepatology (Baltimore, Md.), 65(5), 1512-1525.